Ciplite 50 Injection contains Cisplatin 50mg, a potent chemotherapeutic drug widely used for the treatment of cancers including ovarian, testicular, bladder, lung, and head & neck malignancies. It works by inhibiting DNA replication in cancer cells, effectively controlling tumor growth and progression.
The injectable formulation ensures accurate dosing and rapid systemic action, making it ideal for hospital-based chemotherapy administration. Cisplatin is commonly used in combination therapy protocols to enhance the effectiveness of cancer treatment.
For distributors and resellers, Ciplite 50 Injection is a high-demand oncology product, consistently required in cancer hospitals, oncology centers, chemotherapy wards, and specialized healthcare units. Its critical therapeutic importance ensures continuous institutional demand and recurring orders.
Adding Ciplite 50 Injection to your portfolio strengthens your oncology and hospital-care segment, offering opportunities for bulk hospital supply, institutional tenders, private oncology clinics, export markets, and third-party manufacturing. Its indispensable role in chemotherapy makes it a profitable and strategically essential product for pharmaceutical distributors.